Study of three diabetes medicines in healthy adults after eating
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests how three common diabetes medicines (dapagliflozin, linagliptin, and metformin) are absorbed when taken with food in healthy adults. It helps doctors understand safe dosing and potential interactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 50 years old.
- Your weight is in a healthy range for your height (BMI 18–30).
- You are generally healthy, with no major chronic conditions like heart, kidney, or liver disease.
- You are not taking any regular medications (except birth control) that could interfere.
- You have not participated in another drug trial in the past 6 months or donated blood recently.
- You agree to use non-hormonal birth control during and shortly after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This trial tests how a new combination of drugs (BR3006A, BR3006B, and BR3006C) is absorbed and processed by the body when taken together, compared to a single tablet (BR3006). It is for healthy adults to understand the safety and behavior of the medication.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This trial tests how the body processes different forms of a drug called BR3006 in healthy volunteers. It compares a single tablet (BR3006) to a combination of three separate components (BR3006A, BR3006B, and BR3006C) given together. This helps researchers understand if the combination works the same as the single tablet.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study looks at the safety and effectiveness of adding a third oral diabetes medicine to your current two-drug combination. It is for adults with type 2 diabetes whose blood sugar is not well controlled on metformin plus one other pill.
Hear when a new Type2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.